Technical Analysis
Price | $ 128.88 | 52w range | $ 121.23 - $ 165.00 |
Beta | 1.15 | Volume/ average | 561,193/ 701,410 |
Sector | Healthcare | Dividend | 0.62% |
Universal Health Services, Inc. is an American company that provides hospital and health services, headquartered in Pennsylvania. In 2020, its annual revenues were $ 11.6 billion.
UHS, after an excellent recovery between 2020 and 2021, in recent months has retraced significantly to a level that we consider to be a strong area of support and a possible baseline for bullish upside in the medium term.
The $ 121.00 area has played a very important role since 2015, leading to a bullish recovery or bearish continuation. Given how from March to November 2020 it acted as a resistance, we believe it can now play the role of support for a bullish recovery in the medium term.
MACD, despite being below 0, has begun to move upward despite a decreasing price that lately entered in consolidation.
RSI, after reaching a strong oversold zone, gained ground despite a consolidating price.
In our opinion, the push that brought UHS from $ 65.00 (March 2020) to $ 165.00 (June 2021) is justified as a more than physiological retracement in favour of a bullish recovery.
The positive divergence between RSI and MACD indicators and the price coupled with the breach of the 50MA, which we believe to be imminent, leads us to a bullish analysis for UHS.
Entry range $ 127.00 - $132.00
Target 1 $ 140.00
Target 2 $ 156.00
Target 3 $ 169.00
Stop loss $ 110.00
OTB Global Investments
26 November 2021
Opmerkingen